GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (TSE:3349) » Definitions » Asset Turnover

COSMOS Pharmaceutical (TSE:3349) Asset Turnover : 0.55 (As of Feb. 2024)


View and export this data going back to 2004. Start your Free Trial

What is COSMOS Pharmaceutical Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. COSMOS Pharmaceutical's Revenue for the three months ended in Feb. 2024 was 円238,881 Mil. COSMOS Pharmaceutical's Total Assets for the quarter that ended in Feb. 2024 was 円433,198 Mil. Therefore, COSMOS Pharmaceutical's Asset Turnover for the quarter that ended in Feb. 2024 was 0.55.

Asset Turnover is linked to ROE % through Du Pont Formula. COSMOS Pharmaceutical's annualized ROE % for the quarter that ended in Feb. 2024 was 10.37%. It is also linked to ROA % through Du Pont Formula. COSMOS Pharmaceutical's annualized ROA % for the quarter that ended in Feb. 2024 was 5.33%.


COSMOS Pharmaceutical Asset Turnover Historical Data

The historical data trend for COSMOS Pharmaceutical's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Asset Turnover Chart

COSMOS Pharmaceutical Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.33 2.31 2.20 2.15 2.11

COSMOS Pharmaceutical Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 0.56 0.57 0.54 0.55

Competitive Comparison of COSMOS Pharmaceutical's Asset Turnover

For the Pharmaceutical Retailers subindustry, COSMOS Pharmaceutical's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


COSMOS Pharmaceutical's Asset Turnover Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, COSMOS Pharmaceutical's Asset Turnover distribution charts can be found below:

* The bar in red indicates where COSMOS Pharmaceutical's Asset Turnover falls into.



COSMOS Pharmaceutical Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

COSMOS Pharmaceutical's Asset Turnover for the fiscal year that ended in May. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: May. 2023 )/( (Total Assets (A: May. 2022 )+Total Assets (A: May. 2023 ))/ count )
=827697/( (363052+420967)/ 2 )
=827697/392009.5
=2.11

COSMOS Pharmaceutical's Asset Turnover for the quarter that ended in Feb. 2024 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Feb. 2024 )/( (Total Assets (Q: Nov. 2023 )+Total Assets (Q: Feb. 2024 ))/ count )
=238881/( (436155+430241)/ 2 )
=238881/433198
=0.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


COSMOS Pharmaceutical  (TSE:3349) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

COSMOS Pharmaceutical's annulized ROE % for the quarter that ended in Feb. 2024 is

ROE %**(Q: Feb. 2024 )
=Net Income/Total Stockholders Equity
=23080/222584
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(23080 / 955524)*(955524 / 433198)*(433198/ 222584)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.42 %*2.2057*1.9462
=ROA %*Equity Multiplier
=5.33 %*1.9462
=10.37 %

Note: The Net Income data used here is four times the quarterly (Feb. 2024) net income data. The Revenue data used here is four times the quarterly (Feb. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

COSMOS Pharmaceutical's annulized ROA % for the quarter that ended in Feb. 2024 is

ROA %(Q: Feb. 2024 )
=Net Income/Total Assets
=23080/433198
=(Net Income / Revenue)*(Revenue / Total Assets)
=(23080 / 955524)*(955524 / 433198)
=Net Margin %*Asset Turnover
=2.42 %*2.2057
=5.33 %

Note: The Net Income data used here is four times the quarterly (Feb. 2024) net income data. The Revenue data used here is four times the quarterly (Feb. 2024) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


COSMOS Pharmaceutical Asset Turnover Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


COSMOS Pharmaceutical (TSE:3349) Business Description

Traded in Other Exchanges
N/A
Address
4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013
COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (TSE:3349) Headlines

No Headlines